Designing development programs for non-traditional antibacterial agents

Non-traditional antibacterial agents are challenging to develop. In this Perspective, the authors argue that the distinction between traditional and non-traditional agents has only limited relevance for regulatory purposes, although products with non-traditional goals focused on population-level ben...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: John H. Rex, Holly Fernandez Lynch, I. Glenn Cohen, Jonathan J. Darrow, Kevin Outterson
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
Q
Acceso en línea:https://doaj.org/article/3146f09e95be41bd9cb39854de101287
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3146f09e95be41bd9cb39854de101287
record_format dspace
spelling oai:doaj.org-article:3146f09e95be41bd9cb39854de1012872021-12-02T14:39:16ZDesigning development programs for non-traditional antibacterial agents10.1038/s41467-019-11303-92041-1723https://doaj.org/article/3146f09e95be41bd9cb39854de1012872019-07-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-11303-9https://doaj.org/toc/2041-1723Non-traditional antibacterial agents are challenging to develop. In this Perspective, the authors argue that the distinction between traditional and non-traditional agents has only limited relevance for regulatory purposes, although products with non-traditional goals focused on population-level benefits might benefit from extension of current paradigms.John H. RexHolly Fernandez LynchI. Glenn CohenJonathan J. DarrowKevin OuttersonNature PortfolioarticleScienceQENNature Communications, Vol 10, Iss 1, Pp 1-10 (2019)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
John H. Rex
Holly Fernandez Lynch
I. Glenn Cohen
Jonathan J. Darrow
Kevin Outterson
Designing development programs for non-traditional antibacterial agents
description Non-traditional antibacterial agents are challenging to develop. In this Perspective, the authors argue that the distinction between traditional and non-traditional agents has only limited relevance for regulatory purposes, although products with non-traditional goals focused on population-level benefits might benefit from extension of current paradigms.
format article
author John H. Rex
Holly Fernandez Lynch
I. Glenn Cohen
Jonathan J. Darrow
Kevin Outterson
author_facet John H. Rex
Holly Fernandez Lynch
I. Glenn Cohen
Jonathan J. Darrow
Kevin Outterson
author_sort John H. Rex
title Designing development programs for non-traditional antibacterial agents
title_short Designing development programs for non-traditional antibacterial agents
title_full Designing development programs for non-traditional antibacterial agents
title_fullStr Designing development programs for non-traditional antibacterial agents
title_full_unstemmed Designing development programs for non-traditional antibacterial agents
title_sort designing development programs for non-traditional antibacterial agents
publisher Nature Portfolio
publishDate 2019
url https://doaj.org/article/3146f09e95be41bd9cb39854de101287
work_keys_str_mv AT johnhrex designingdevelopmentprogramsfornontraditionalantibacterialagents
AT hollyfernandezlynch designingdevelopmentprogramsfornontraditionalantibacterialagents
AT iglenncohen designingdevelopmentprogramsfornontraditionalantibacterialagents
AT jonathanjdarrow designingdevelopmentprogramsfornontraditionalantibacterialagents
AT kevinoutterson designingdevelopmentprogramsfornontraditionalantibacterialagents
_version_ 1718390647220600832